Short Lead Time for Rapid Test Rapid Antigen - KaiBiLi COVID-19 Antigen – Genesis
Short Lead Time for Rapid Test Rapid Antigen - KaiBiLi COVID-19 Antigen – Genesis Detail:
Introduction
COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main symptoms including manifestations include fever, fatigue and dry cough, nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
The KaiBiLiTM COVID-19 Antigen Rapid Test Device is an in vitro diagnostic test based on the principle of immunochromatography for the qualitative detection of 2019 Novel Coronavirus nucleocapsid protein antigens in nasal swab or nasopharyngeal swab. The detection is based on the antibodies which were developed specifically recognizing and reacting with the nucleoprotein of 2019 Novel Coronavirus. It is intended to aid in the rapid diagnosis of SARS-CoV-2 infection.
This assay is intended for rapid screening in laboratory. This test should be conducted by trained technician, wearing appropriate personal protective equipment (PPE).
Detection
The qualitative detection of 2019 Novel Coronavirus nucleocapsid protein antigens in nasal swab or nasopharyngeal swab.
Specimen
Nasal or nasopharyngeal
Limit of Detection (LoD)
2019 Novel Coronavirus: 140 TCID50/mL
ACCURACY （Nasal swab）
Positive Percent Agreement: 96.6%
Negative Percent Agreement:100%
Overall Percent Agreement: 98.9%
ACCURACY(Nasopharyngeal swab）
Positive Percent Agreement: 97.0%
Negative Percent Agreement:98.3%
Overall Percent Agreement: 97.7%
Time to Results
Read results at 15minutes and no more than 30 minutes.
Kit storage conditions
2~30°C.
Contents
|
Description |
Qty |
| COVID-19 antigen test devices |
20 |
| Sterilized swabs |
20 |
| Extraction tubes (with 0.5mL extraction buffer) |
20 |
| Nozzles with filter |
20 |
| Tube Stand |
1 |
| Package Insert |
1 |
Ordering Information
|
Product |
Cat.No. |
Contents |
|
KaiBiLiTM COVID-19 Antigen |
P211139 |
20 Tests |
Product detail pictures:
Related Product Guide:
Our advantages are reduced prices,dynamic product sales workforce,specialized QC,solid factories,superior quality services for Short Lead Time for Rapid Test Rapid Antigen - KaiBiLi COVID-19 Antigen – Genesis , The product will supply to all over the world, such as: Gambia, Mali, Johannesburg, We aim to build a famous brand which can influence a certain group of people and light up the whole world. We want our staff to realize self-reliance, then achieve financial freedom, lastly obtain time and spiritual freedom. We do not focus on how much fortune we can make, instead we aim to obtain high reputation and be recognized for our products. As a result, our happiness comes from our clients satisfaction rather than how much money we earn. Ours team will do best for you always.
By Merry from Algeria - 2017.01.28 19:59
With a positive attitude of "regard the market, regard the custom, regard the science", the company works actively to do research and development. Hope we have a future business relationships and achieving mutual success.
By Riva from Danish - 2017.09.09 10:18
